Hessekiel Jeffrey (CIK 1599803) reported 9 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-03-17). Recent activity: Buy CYTK (20,646 shares), Buy CYTK (87,297 shares), Sell EXEL (34,035 shares), Sell EXEL (25,000 shares), Buy EXEL (154,070 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-17 | CYTOKINETICS INC (CYTK) | Chief Legal & Admin Officer | Buy | 20,646 | $0 |
| 2025-11-17 | CYTOKINETICS INC (CYTK) | Chief Legal & Admin Officer | Buy | 87,297 | $0 |
| 2025-05-16 | EXELIXIS, INC. (EXEL) | EVP & General Counsel | Sell | 34,035 | $1.5M |
| 2025-05-16 | EXELIXIS, INC. (EXEL) | EVP & General Counsel | Sell | 25,000 | $1.2M |
| 2025-03-31 | EXELIXIS, INC. (EXEL) | EVP & General Counsel | Buy | 154,070 | $0 |
| 2025-02-28 | EXELIXIS, INC. (EXEL) | EVP & General Counsel | Buy | 52,192 | $0 |
| 2025-02-19 | EXELIXIS, INC. (EXEL) | EVP & General Counsel | Sell | 18,134 | $634,690 |
| 2025-01-17 | EXELIXIS, INC. (EXEL) | EVP & General Counsel | Buy | 118,780 | $0 |
| 2025-01-17 | EXELIXIS, INC. (EXEL) | EVP & General Counsel | Sell | 26,289 | $979,791 |
Source: SEC Form 4 filings · as of 2026-03-17